行情

OPK

OPK

OPKO Health
NASDAQ

实时行情|Nasdaq Last Sale

1.560
+0.030
+1.96%
盘后: 1.560 0 0.00% 16:42 12/13 EST
开盘
1.540
昨收
1.530
最高
1.580
最低
1.510
成交量
397.42万
成交额
--
52周最高
3.935
52周最低
1.330
市值
10.38亿
市盈率(TTM)
-3.2629
分时
5日
1月
3月
1年
5年

分析师评级

4位分析师的综合评级

强力推荐

免责声明:分析师观点仅供投资者决策参考,不构成任何买卖投资建议。

EPS

OPK 新闻

  • 英国政府计划脱欧法案 为NHS提供多年资金
  • 新浪财经综合.2小时前
  • “生娃”不积极 低生育率持续困扰韩国社会
  • 新华网.3小时前
  • 明年2月政府改组 约翰逊或解雇三分之一内阁官员
  • 新浪财经综合.4小时前
  • 结局锁定 特朗普盟友称弹劾案或2020年1月结束进程
  • 中国新闻网.5小时前

更多

所属板块

制药
-0.74%
制药与医学研究
-0.32%

热门股票

名称
价格
涨跌幅

OPK 简况

OPKO Health, Inc. is a healthcare company. Its segments include Pharmaceutical, Diagnostics and Corporate. Pharmaceutical consists of the pharmaceutical operations in Chile, Mexico, Ireland, Israel and Spain and its pharmaceutical research and development operations. Diagnostics consists of the clinical laboratory operations in Bio-Reference Laboratories (Bio-Reference) and its point-of-care operations. Through Bio-Reference, it operates laboratory divisions, such as Bio-Reference, GenPath (Oncology), GenPath (Women's Health), GeneDx and Laboratorio Bueno Salud. As of December 31, 2016, it had one commercial stage pharmaceutical product and several pharmaceutical compounds and technologies in various stages of research and development for a range of indications and conditions, including Renal Products, Biologics, hGH-CTP, Factor VII, Oxyntomodulin, active pharmaceutical ingredients, Oligonucleotide Therapeutics, NK-1 Program, Asthma and chronic obstructive pulmonary disease.
展开

Webull提供Opko Health Inc.的股票价格,实时市场报价,专业分析师评级,深度图表和免费的股票新闻,以帮助您做出投资决策。